Announcement on Voluntary Disclosure Regarding the Completion of First Subject Enrollment in Phase Ⅰa Clinical Trial for APL-2302

About this update from Jiangsu Yahong Meditech Co., Ltd. Class A

Announcement on Voluntary Disclosure Regarding the Completion of First Subject Enrollment in Phase Ⅰa Clinical Trial for APL-2302The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Yahong Meditech Co., Ltd. Class A